GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 2901 - 2950 of 39437 in total
PDB ID UniProt ID Title Descriptor ▲
2IWG P19474 COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC IG GAMMA-1 CHAIN C, 52 KDA RO PROTEIN
3ZO0 P01863 Mouse IgG2a in complex with mouse TRIM21 PRYSPRY IG GAMMA-2A CHAIN C REGION, A ALLELE, E3 UBIQUITIN-PROTEIN LIGASE TRIM21 (E.C.6.3.2.-)
3ZO0 Q62191 Mouse IgG2a in complex with mouse TRIM21 PRYSPRY IG GAMMA-2A CHAIN C REGION, A ALLELE, E3 UBIQUITIN-PROTEIN LIGASE TRIM21 (E.C.6.3.2.-)
2FBJ P01810 REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION IGA FAB FRAGMENT (J539) (GALACTAN-BINDING)
2FBJ 437099 REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION IGA FAB FRAGMENT (J539) (GALACTAN-BINDING)
1CLY 1CLY IGG FAB (HUMAN IGG1, KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER IGG FAB (HUMAN IGG1, KAPPA), METHYL NONANOATE (ESTER)
1CLZ P22436 IGG FAB (IGG3, KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER IGG FAB (IGG3, KAPPA), METHYL NONANOATE (ESTER)
1CLZ PC4203 IGG FAB (IGG3, KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER IGG FAB (IGG3, KAPPA), METHYL NONANOATE (ESTER)
1IGF S38864 CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS IGG1 FAB' FRAGMENT (B13I2)
1IGF PC4203 CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS IGG1 FAB' FRAGMENT (B13I2)
2IGF S38864 CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS IGG1 FAB' FRAGMENT (B13I2) COMPLEX WITH PEPTIDE (RESIDUES 69-87 OF MYOHEMERYTHRIN)
2IGF PC4203 CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS IGG1 FAB' FRAGMENT (B13I2) COMPLEX WITH PEPTIDE (RESIDUES 69-87 OF MYOHEMERYTHRIN)
2IGF P02247 CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS IGG1 FAB' FRAGMENT (B13I2) COMPLEX WITH PEPTIDE (RESIDUES 69-87 OF MYOHEMERYTHRIN)
1MFB 208365 HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA IGG1-LAMBDA SE155-4 FAB
1MFB 387376 HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA IGG1-LAMBDA SE155-4 FAB
1MFC 208365 HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA IGG1-LAMBDA SE155-4 FAB
1MFC 387376 HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA IGG1-LAMBDA SE155-4 FAB
1MFD 208365 THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE IGG1-LAMBDA SE155-4 FAB
1MFD 387376 THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE IGG1-LAMBDA SE155-4 FAB
1HZH P0DOX5 CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN)
1HZH 1HZH CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN)
1HZH P0DOX5 CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN)
1HZH 1HZH CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN)
1HZH Q8TCD0 CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN)
1HZH Q8TCD0 CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN)
1FC2 P02976 Crystallographic Refinement and Atomic Models of a Human FC Fragment and its Complex with Fragment B of Protein A from Staphylococcus Aureus at 2.9-and 2.8-Angstroms Resolution IMMUNOGLOBULIN FC AND FRAGMENT B OF PROTEIN A COMPLEX
1FC2 Y14737 Crystallographic Refinement and Atomic Models of a Human FC Fragment and its Complex with Fragment B of Protein A from Staphylococcus Aureus at 2.9-and 2.8-Angstroms Resolution IMMUNOGLOBULIN FC AND FRAGMENT B OF PROTEIN A COMPLEX
1MCO 243866 THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION IMMUNOGLOBULIN G1 (IGG1) (MCG) WITH A HINGE DELETION
1MCO S14675 THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION IMMUNOGLOBULIN G1 (IGG1) (MCG) WITH A HINGE DELETION
1IVG P06820 STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18)
1INW P06820 A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH APANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-BETA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID
1IVD P06820 STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH AROMATIC BANA105 INHIBITOR (4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID)
1IVC P06820 STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH AROMATIC BANA106 INHIBITOR (4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID)
1IVE P06820 STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH AROMATIC BANA108 INHIBITOR (4-(ACETYLAMINO)-3-AMINOBENZOIC ACID)
1IVF P06820 STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH DANA INHIBITOR (2-DEOXY-2,3-DIDEHYDRO-D-N-ACETYLNEURAMINIC ACID)
1INX P06820 A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH EPANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-ALPHA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID
1INH P06820 INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA111 INHIBITOR INFLUENZA A SUBTYPE N2 NEURAMINIDASE, 4-(ACETYLAMINO)-3-[(AMINOACETYL)AMINO]BENZOIC ACID
1ING P06820 INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR INFLUENZA A SUBTYPE N2 NEURAMINIDASE, 4-(ACETYLAMINO)-3-[(HYDROXYACETYL)AMINO]BENZOIC ACID
1INY P03472 A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES INFLUENZA A SUBTYPE N9 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH EPANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-ALPHA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID
1INV P03474 A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES INFLUENZA B/LEE/40 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH EPANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-ALPHA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID
1IVB P03474 STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH BANA105 INHIBITOR (4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID)
1INF P03474 INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE COMPLEXED WITH BANA113 INHIBITOR INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE, 4-(ACETYLAMINO)-3-GUANIDINOBENZOIC ACID
1EO8 P03437 INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
1EO8 7159939 INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
1EO8 7159941 INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
1LRT P50097 CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRITRICHOMONAS FOETUS INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE: STRUCTURAL CHARACTERIZATION OF NAD+ SITE IN MICROBIAL ENZYME INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE (E.C.1.1.1.205)
4CAK P08514 Three-dimensional reconstruction of intact human integrin alphaIIbbeta3 in a phospholipid bilayer nanodisc INTEGRIN ALPHA-IIB, INTEGRIN BETA-3
4CAK P05106 Three-dimensional reconstruction of intact human integrin alphaIIbbeta3 in a phospholipid bilayer nanodisc INTEGRIN ALPHA-IIB, INTEGRIN BETA-3
2VDO P08514 Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide, HHLGGAKQAGDV INTEGRIN ALPHA-IIB, INTEGRIN BETA-3, FIBRINOGEN, GAMMA POLYPEPTIDE, MONOCLONAL ANTIBODY 10E5 HEAVY CHAIN, MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN
2VDO P05106 Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide, HHLGGAKQAGDV INTEGRIN ALPHA-IIB, INTEGRIN BETA-3, FIBRINOGEN, GAMMA POLYPEPTIDE, MONOCLONAL ANTIBODY 10E5 HEAVY CHAIN, MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024